These results demonstrate that PRMT5 regulates a metabolic shift towards glycolysis and inhibits mitochondria oxidative phosphorylation in GBM cells, and PRMT5 downregulation results in decreased invasion, migration, and growth in GBM cells. Here, PRMT5 is linked to glioblastoma.